Know Cancer

or
forgot password

    • cancer clinical trials in la crosse, WI

    • Everolimus in Treating Patients With Stage IV Melanoma
    Franciscan Skemp Healthcare - La Crosse Campus
    La Crosse, Wisconsin 54601
    Melanoma (Skin)
    Gefitinib in Treating Patients With Locally Advanced Esophageal Cancer
    Franciscan Skemp Healthcare - La Crosse Campus
    La Crosse, Wisconsin 54601
    Esophageal Cancer
    Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma
    Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center
    La Crosse, Wisconsin 54601
    Sarcoma
    Pemetrexed Plus Gemcitabine or Carboplatin for Patients With Advanced Malignant Pleural Mesothelioma
    Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center
    La Crosse, Wisconsin 54601
    Mesothelioma
    Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer
    Gundersen Lutheran Center for Cancer and Blood
    La Crosse, Wisconsin 54601
    Lung Cancer
    Bortezomib With or Without Irinotecan in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center
    La Crosse, Wisconsin 54601
    Head and Neck Cancer
    Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer
    Franciscan Skemp Healthcare - La Crosse Campus
    La Crosse, Wisconsin 54601
    Breast Cancer
    Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer
    Franciscan Skemp Healthcare
    La Crosse, Wisconsin 54601-4796
    Pancreatic Cancer
    Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
    Franciscan Skemp Healthcare - La Crosse Campus
    La Crosse, Wisconsin 54601
    Lung Cancer
    Safety And Efficacy In Subjects With Relapsed Or Refractory Aggressive Non-Hodgkin’s Lymphoma
    Gunderson Clinic, Ltd
    La Crosse, Wisconsin 54601
    Non-Hodgkins Lymphoma
    Lenalidomide (Revlimid®, CC-5013) in Subjects With Relapsed or Refractory Indolent Non-Hodgkin’s Lymphoma
    Gunderson Clinic, Ltd.
    La Crosse, Wisconsin 54601
    Non-Hodgkins Lymphoma
    S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas
    Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center
    La Crosse, Wisconsin 54601
    Sarcoma
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Mayo Clinic Health System-Franciscan Healthcare
    La Crosse, Wisconsin 54601
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma
    Gundersen Lutheran Center for Cancer and Blood
    La Crosse, Wisconsin 54601
    Brain and Central Nervous System Tumors
    Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma
    Gundersen Lutheran Center for Cancer and Blood
    La Crosse, Wisconsin 54601
    Lymphoma
    Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary
    Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center
    La Crosse, Wisconsin 54601
    Carcinoma of Unknown Primary, Pain
    Donepezil in Treating Patients Who Have Undergone Radiation Therapy for Brain Tumors
    Gundersen Lutheran Center for Cancer and Blood
    La Crosse, Wisconsin 54601
    Brain and Central Nervous System Tumors, Cognitive/Functional Effects, Fatigue, Metastatic Cancer, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity
    Methylphenidate in Treating Patients With Fatigue Caused by Cancer
    Franciscan Skemp Healthcare - La Crosse Campus
    La Crosse, Wisconsin 54601
    Fatigue, Unspecified Adult Solid Tumor, Protocol Specific
    Carboplatin and ABI-007 in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
    Franciscan Skemp Healthcare - La Crosse Campus
    La Crosse, Wisconsin 54601
    Melanoma (Skin)
    Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
    Gundersen Lutheran
    La Crosse, Wisconsin 54601
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor
    Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ
    Franciscan Skemp Healthcare - La Crosse Campus
    La Crosse, Wisconsin 54601
    Breast Cancer, Dermatologic Complications, Radiation Toxicity, Skin Reactions Secondary to Radiation Therapy
    cRisk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    Gundersen Lutheran Center for Cancer and Blood
    La Crosse, Wisconsin 54601
    Leukemia
    Study Evaluating Effects of CX-3543 in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
    Gundersen Lutheran Medical Center
    La Crosse, Wisconsin 54601
    B-Cell Chronic Lymphocytic Leukemia
    Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Gundersen Lutheran Center for Cancer and Blood
    La Crosse, Wisconsin 54601
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    R-(-)-Gossypol Acetic Acid, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer
    Gundersen Lutheran
    La Crosse, Wisconsin 54601
    Extensive Stage Small Cell Lung Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Ph 2 Bortezomib, Dexamethasone, + Doxorubicin With ALCAR for Previously Treated Multiple Myeloma
    Gundersen Lutheran
    La Crosse, Wisconsin 54601
    Multiple Myeloma
    Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving Idursulfase
    Franciscan Skemp Healthcare
    La Crosse, Wisconsin 54601-4796
    Hunter Syndrome, Mucopolysaccharidosis II
    Study of Vandetanib Combined With Chemotherapy to Treat Advanced Non-small Cell Lung Cancer
    Gundersen Lutheran
    La Crosse, Wisconsin 54601
    Lung Cancer, Non Small Cell Lung Cancer
    Radiation Therapy or Observation After Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer
    Franciscan Skemp Healthcare - La Crosse Campus
    La Crosse, Wisconsin 54601
    Lung Cancer
    Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
    Gundersen Lutheran
    La Crosse, Wisconsin 54601
    Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes
    A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Gundersen Lutheran Center for Cancer and Blood
    La Crosse, Wisconsin 54601
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Carboplatin and Paclitaxel Combined With Cetuximab and/or Cixutumumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Gundersen Lutheran
    La Crosse, Wisconsin 54601
    Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    To Demonstrate Superiority of Decitabine Over Azacitidine in Subjects With Intermediate- or High-risk MDS.
    Gunderson Clinic Ltd.
    La Crosse, Wisconsin 54601
    Myelodysplastic Syndromes
    Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis
    Gundersen Lutheran
    La Crosse, Wisconsin 54601
    Light Chain Deposition Disease, Primary Systemic Amyloidosis